Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
Status:
Terminated
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
1 out of 8 children, adolescents, and young adults suffer from an anxiety disorder. Studies
over the past decade show that selective serotonin-reuptake inhibitors (SSRIs), a class of
medication that treats anxiety in adults, also works well in young adults, children, and
adolescents with anxiety disorders, but only for about 50%. 50% will have undergone treatment
for several months before it will be established that the medication is not working to treat
the anxiety. The purpose of this study is to find a test that will predict treatment outcome
from the beginning based on behavioral and biological measures.